Skip to main content
SpringerLink
Log in

Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease

  • LETTER TO THE EDITOR
  • Published:
Transplant International

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Visceral and Transplantation Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30 625 Hannover, Germany e-mail: kuse.ernst@mh-hannover.de Tel.: + 49-5 11-5 32 21 25 Fax: + 49-5 11-5 32 40 10, , , , , , DE

    E. R. Kuse

  2. Department of Anesthesiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30 625 Hannover, Germany, , , , , , DE

    Karsten Jaeger

Authors
  1. E. R. Kuse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karsten Jaeger
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 27 June 2000 Accepted: 19 September 2000

About this article

Cite this article

Kuse, E., Jaeger, K. Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease. Transpl Int 14, 55 (2001). https://doi.org/10.1007/s001470050744

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001470050744

Keywords

Search

Navigation